Cargando…
Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach
INTRODUCTION: Finasteride (FIN) is known as type II 5α-reductase inhibitor, which has been approved for the treatment and prevention of androgenetic alopecia. Administration of FIN by oral route has led to undesirable systemic side effects that include mood disturbance, gynecomastia, decreased libid...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070339/ https://www.ncbi.nlm.nih.gov/pubmed/30104862 http://dx.doi.org/10.2147/DDDT.S171888 |